This article addresses how the development and use of mobile technologies and devices is expanding at an incredibly fast pace and is changing, and in fact revolutionizing, the way patients and healthcare providers interact.
This is a panelist document list.
One of the biggest challenges in managing privacy programs in North America is recognizing and reconciling the significant data implications between the United States and Canada that apply to otherwise similar products and services. Attendees will learn key differences, helpful similarities, and strategies for managing a comprehensive approach to privacy, including what to do with a cross-border data breach.
This article provides an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies.
This articles addresses pharmaceutical antitrust in Switzerland.
The purpose of this ACC guide (InfoPAK) is to provide an overview of opportunities available as a result of Big Data — the ability to collect, process, and interpret massive amounts of information — in healthcare, and the U.S. regulatory regime that is in part driving such industry change. It provides an overview of the key US federal and state laws pertaining to the collection and secondary use of health data, and suggests strategies and best practices for addressing health privacy and data ownership concerns.
The purpose of this ACC guide (InfoPAK) is to provide an overview of the investigation and litigation of whistleblower claims with a focus on claims under the Sarbanes-Oxley and Dodd-Frank Acts.